Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
Latest from News
The United States and Iran failed to reach an agreement after 21 hours of talks in
The Philippine National Police (PNP) seized about ₱1.8 billion worth of illegal goods and arrested several
Senior Citizens Rep. Rodolfo Ordanes reminded seniors that they will receive a 40% fare discount on
Energy Secretary Sharon Garin said diesel prices are expected to drop by at least ₱20.89 per
Soaring liquefied petroleum gas (LPG) prices driven by the Middle East conflict are hurting street food